Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

PaperCitations, authors & open-access status

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 126 citations, 2020 year and gold oa status.

126
Citations
2020
Year
gold
OA Status

Related on ScholarIQ

Yosuke Okada
Author
Cardiovascular Diabetology
Journal
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Diabetes Management and Research
Topic
Pancreatic function and diabetes
Topic
470M+ articles · free account